Metoprolol and Coronary Artery Bypass Grafting Surgery: Does Intraoperative Metoprolol Attenuate Acute β-Adrenergic Receptor Desensitization during Cardiac Surgery?

Anesthesia and Analgesia

Volumn 98, Issue 5, 2004, Pages 1224-1231

  Booth, John V ^a   Ward, Erin E ^a   Colgan, Kelly C ^a   Funk, Bonita L ^a   El Moalem, Habib ^a   Smith, Michael P ^a   Milano, Carmelo ^a   Smith, Peter K ^a   Newman, Mark F ^a   Schwinn, Debra A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; METOPROLOL; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DENSITY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; HEART ATRIUM MUSCLE; HEART MUSCLE; HEART OUTPUT; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEMODYNAMIC MONITORING; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DOWN REGULATION; TIME;

EID: 11144354563     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000112325.66981.03     Document Type: Article

References (46)

1. Royster R, Butterworth J, Prough D, et al. Preoperative and intraoperative predictors of inotropic support and long-term outcome in-patients having coronary artery bypass grafting. Anesth Analg 1991;72:720-36.
2. Schwinn D, Leone B, Spahn D, et al. Desensitization of myocardial β-adrenergic receptors during cardiopulmonary bypass: evidence for early uncoupling and late downregulation. Circulation 1991;84:2559-67.
3. Toleikis PM, Tomlinson CW. Myocardial functional preservation during ischemia: influence of beta blocking agents. Mol Cell Biochem 1997;176:205-10.
4. Richard V, Kaeffer N, Thuillez C. Delayed protection of the ischemic heart: from pathophysiology to therapeutic applications. Fundam Clin Pharmacol 1996;10:409-15.
5. Geissler HJ, Davis KL, Buja LM, et al. Esmolol and cardiopulmonary bypass during reperfusion reduce myocardial infarct size in dogs. Ann Thoracic Surg 2001;72:1964-9.
6. Shattock MJ. Myocardial stunning: do we know the mechanism? Basic Res Cardiol 1997;92:18-22.
7. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 1999;138:69-75.
8. Booth JV, Landolfo KP, Chesnut LC, et al. Acute depression of myocardial beta-adrenergic receptor signaling during cardiopulmonary bypass: impairment of the adenylyl cyclase moiety. Anesthesiology 1998;89:602-11.
9. Gerhardt MA, Booth JV, Chesnut LC, et al. Acute myocardial beta-adrenergic receptor dysfunction after cardiopulmonary bypass in patients with cardiac valve disease. Circulation 1998;98: 11275-81.
10. Teoh K, Christakis G, Weisel R, et al. Increased risk of urgent revascularization. J Thorac Cardiovasc Surg 1987;93:291-9.
11. Reves J, Karp R, Buttner E, et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 1982;66:49-55.
12. Smiley R, Vulliemoz Y. Cardiac surgery causes desensitization of the β-adrenergic receptor system of human lymphocytes. Anesth Analg 1992;74:212-8.
13. Booth JV, Spahn DR, McRae RL, et al. Esmolol improves left ventricular function via enhanced beta-adrenergic receptor signaling in a canine model of coronary revascularization. Anesthesiology 2002;97:162-9.
14. Kozlik-Feldmann R, Kramer HH, Wicht H, et al. Distribution of myocardial beta-adrenoceptor subtypes and coupling to the adenylate cyclase in children with congenital heart disease and implications for treatment. J of Clinical Pharmacology 1993;33: 588-95.
15. Kaumann AJ, Sanders L, Lynham JA, et al. Beta 2-adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a camp pathway in human atrium. Mol Cell Biochem 1996;163-164:113-23.
16. Brodde O, Zerkowski H, Schranz D, et al. Age-dependent changes in the β-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol 1995;26: 20-6.
17. Smiley R, Pantuck C, Chadburn A, Knowles D. Down-regulation and desensitization of the β-adrenergic receptor system of human lymphocytes after cardiac surgery. Anesth Analg 1993;77:653-61.
18. Salomon NW, Plachetka JR, Copeland JG. Comparison of dopamine and dobutamine following coronary artery bypass grafting. Ann Thoracic Surg 1982;33:48-54.
19. Sato Y, Matsuzawa H, Eguchi S. Comparative study of effects of adrenaline, dobutamine and dopamine on systemic hemodynamics and renal blood flow in patients following open heart surgery. Japan Circulation J 1982;46:1059-72.
20. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Ann Biochemistry 1974;58:541-8.
21. Lohse M, Englelhardt S, Danner S, Bohm M. Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure. Basic Res Cardiol 1996;2:29-34.
22. Ferguson S, Barak L, Zhang J, Caron M. G-protein-coupled receptor regulation: role of G-proteion-coupled receptor kinases and arrestins. J Physiol Pharmacol 1996;74:1095-110.
23. Sterne-Marr R, Benovic J. Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam Horm 1995;51: 193-234.
24. Lohse M. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1993;1179:171-88.
25. Pitcher J, Payne E, Csortos C et al. The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. Proc Natl Acad Sci U S A 1995;92:8343-7.
26. Maisel A, Motulsky H, Insel P. Externalization of β-adrenergic receptors promoted by myocardial ischemia. Science 1985;230: 183-6.
27. Strasser R, Marquetant R, Kubler W. Adrenergic receptors and sensitization of adenylyl cyclase in acute myocardial ischemia. Circulation 1990;82(suppl II):23-9.
28. Strasser RH, Marquetant R. Supersensitivity of the adenylyl cyclase system in acute myocardial ischemia: evaluation of three independent mechanisms. Basic Res Cardiol 1990;85:67-78.
29. Yu S, Lefkowitz R, Hausdorff W. β-adrenergic receptor desensitization: a potential mechanism of receptor resensitization. J Biol Chem 1993;268:337-41.
30. Ungerer M, Kessebohm K, Kronsbein K, et al. Activation of beta-adrenergic receptor kinase during myocardial ischemia. Circ Res 1996;79:455-60.
31. Strasser RH, Braun-Dullaeus R, Walendzik H, Marquetant R. Alpha 1-receptor-independent activation of protein kinase C in acute myocardial ischemia. Mechanisms for sensitization of the adenylyl cyclase system. Circ Res 1992;70:1304-12.
32. Schomig A. Catecholamines in myocardial ischemia: systemic and cardiac release. Circulation 1990;82:1113-22.
33. Black P, Van Devanter S, Cohn L. Effects of hypothermia on systemic and organ system metabolism and function. J Surg Res 1976;20:49-63.
34. Lee T, Grocott H, Maniate J, et al. High spinal anesthesia for cardiac surgery: effects on β-adrenergic receptor function, stress response, and hemodynamics. Anesthesiology 2003;98:499-510.
35. Bristow M, Gilbert E, Abraham W, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996;94: 2807-16.
36. Bristow MR. What type of beta-blocker should be used to treat chronic heart failure? Circulation 2000;102:484-6.
37. Maisel A. Beneficial effects of metoprolol treatment in congestive heart failure: reversal of sympathetic-induced alterations of immunologic function. Circulation 1994;90:1774-80.
38. Cork R, Azari D, McQueen K, et al. Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography. Anesth Analg 1995;81:219-24.
39. Warner W, Anton A, Andersen T, Swofford L. Ventricular fibrillation and catecholamine responses during profound hypothermia in dogs. Anesthesiology 1970;33:43-51.
40. Gottlieb SS, McCarter RJ. Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction. Am J Cardiol 2001;87:823-6.
41. McQuitty C, Johnston W, Nelson S. β-adrenergic receptor sensitization on cardiopulmonary bypass by noncatecholamine mediators. Anesth Analg 1996;82:SCA28.
42. Wills-Karp M, Uchida Y, Lee JY, et al. Organ culture with proinflammatory cytokines reproduces impairment of the beta-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am J Respir Cell Mol Biol 1993;8:153-9.
43. Hravnak M, Hoffman LA, Saul MI, et al. Predictors and impact of atrial fibrillation after isolated coronary artery bypass grafting. Crit Care Med 2002;30:330-7.
44. Hravnak M, Hoffman LA, Saul MI, et al. Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. Ann Thoracic Surg 2001;71:1491-5.
45. Wurdeman RL, Mooss AN, Mohiuddin SM, Lenz TL. Amiodarone versus sotalol as prophylaxis against atrial fibrillation/ flutter after heart surgery: a meta-analysis. Chest 2002;121: 1203-10.
46. Tokmakoglu H, Kandemir O, Gunaydin S, et al. Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation. Eur J Cardiothoracic Surg 2002;21:401-5.